ℹ️
🇬🇧
Search
Search for publications relevant for "adduction"
adduction
Publication
Class
Person
Publication
Programmes
Export current view
publication
DNA adducts in genotoxicology
2006 |
Faculty of Science
publication
Ellipticine forms covalent DNA adducts in rats with properties similar to adducts formed in vitro after its activation by cytochromes P450 or peroxidases
2001 |
Faculty of Science
publication
32P-Postlabeling Analysis of DNA Adducts
2013 |
Faculty of Science
publication
Covalent DNA Adduct Formation Mediated by Cytochromes 450
2004 |
Faculty of Science
publication
Monitoring of DNA adducts in humans and P-32-postlabelling methods. A review
2004 |
Faculty of Science
publication
Results of treatment of residual adduction of the forefoot using basal metatarsal osteotomy
2014 |
Publication without faculty affiliation
publication
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabeling analysis of DNA adduct formation
2001 |
Faculty of Science
publication
Carcinogenic aristolochic acid upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs neprophathy
2002 |
Faculty of Science
publication
DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique
2002 |
Faculty of Science
publication
Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the P-32-postlabeling technique
2012 |
Faculty of Science, Second Faculty of Medicine
publication
Formation of DNA Adducts by Ellipticine and Its Micellar Form in Rats - A Comparative Study
2014 |
Faculty of Science
publication
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
2009 |
Second Faculty of Medicine
publication
DNA adducts, strand breaks and micronuclei in mice exposed to styrene by inhalation
2001 |
Third Faculty of Medicine
publication
The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine
2006 |
Faculty of Science
publication
Human and rat cytochromes P450 activate anticancer drug ellipticine to metabolites forming identical DNA-adducts
2002 |
Faculty of Science
publication
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
2015 |
Faculty of Science
publication
Formation, Persistence, and Identification of DNA Adducts Formed by the Carcinogenic Environmental Pollutant o-Anisidine in Rats
2012 |
Faculty of Science, Central Library of Charles University
publication
Direct evidence for the formation of deoxyribonucleotide adducts from carcinogenic N-nitroso-N-methylaniline revealed by the P-32-postlabeling technique
1999 |
Faculty of Science
publication
Styrene and Styrene Oxide: Their Metabolism and Analytical Methods for Determination of Their Adducts with Proteins
2009 |
Faculty of Science
publication
Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action
2004 |
Faculty of Science
publication
Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells
2007 |
Faculty of Science
publication
Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA
2008 |
Faculty of Science
publication
Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part I: Bulky DNA adducts
2009 |
Second Faculty of Medicine
publication
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
2007 |
Faculty of Science, Second Faculty of Medicine
publication
Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro
2015 |
Faculty of Science, Second Faculty of Medicine
publication
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by P-32-postlabeling
2018 |
Faculty of Science
publication
Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
Faculty of Science
publication
Structure of bis[ethyl (trifluoroacetyl)acetato]copper(II) and its adduct with 4-(dimethylamino)pyridine: EPR and X-ray study
2004 |
Faculty of Science
publication
Formation and persistence of DNA adducts of anticancer drug ellipticine in rats
2007 |
Faculty of Science
publication
Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine
2007 |
Second Faculty of Medicine